WHO Global Cancer Report 2026: Immunotherapy Is Transforming Cancer Care, But Access Remains the Biggest Challenge
Cancer immunotherapy has fundamentally changed modern oncology. Immune checkpoint inhibitors have converted diseases once considered rapidly fatal into cancers where long-term survival is now…
Read the full articleYou might also wanna read
Progress against cancer not shared by poorer countries, WHO report finds
‘Persistent’ inequities found to exist in access to prevention, diagnosis, treatment and care, annual global review says Remarkable scientif
Cancer therapies in 2026: a new era of hope
Cancer therapies in 2026: a new era of hope newspress_en Tue, 07/07/2026 - 11:15 Infographics A 2024 report by the International Agency for
The immunology of human breast cancer
Immunotherapy with ICIs transforms melanoma & lung cancer care, but most breast cancers, except triple-negative ones, resist. PMID:42151556,
Cancer to affect 92% of world's population in some way: WHO
A new WHO report warns cancer will touch 92% of the world’s population, either directly or via close family, turning it into a major global
Mapping the TCR landscape: computational tools empowering translational immunology and therapy design
Introduction Cancer immunotherapy harnesses the body’s own immune system to eliminate malignant cells by enhancing or redirecting the immune
jitc.bmj.com·16d ago
Managing Gastrointestinal Toxicities from Immune Checkpoint Inhibitors in Cancer Patients
Gastrointestinal side effects are among the most important issues to address with patients starting on immune checkpoint inhibitors.
mdsc.pe·1d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.